Clovis Oncology, Inc. Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31)
Clovis Oncology, Inc. had Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) of $269.01 million as of 2013-12-31, per its 10-K filed 2014-02-28.
Discontinued › Notes
us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage · last filed 2014-02-28
- 2013-12-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $269.01M.
- 2013-09-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $239.81M.
- 2013-06-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $219.49M.
- 2013-03-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $200.15M.
| Period end | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) |
|---|---|
| 2013-12-31 | $269.01M 10-K · filed 2014-02-28 |
| 2013-09-30 | $239.81M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $219.49M 10-Q · filed 2013-08-07 |
| 2013-03-31 | $200.15M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $184.48M 10-K · filed 2014-02-28 |
| 2012-09-30 | $163.42M 10-Q · filed 2012-11-14 |
| 2012-06-30 | $145.16M 10-Q · filed 2012-08-10 |
| 2012-03-31 | $129.50M 10-Q · filed 2012-05-11 |
| 2011-12-31 | $110.50M 10-K · filed 2013-03-14 |